SELLAS Life Sciences Group, Inc. Public Float
SELLAS Life Sciences Group, Inc. (SLS) had Public Float of $219.13 million as of 2025-06-30, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-19
- 2025-06-30: Entity Public Float $219.13M.
- 2024-06-30: Entity Public Float $68.57M.
- 2023-06-30: Entity Public Float $44.40M.
- 2022-06-30: Entity Public Float $45.79M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $219.13M 10-K · filed 2026-03-19 |
| 2024-06-30 | $68.57M 10-K · filed 2025-03-20 |
| 2023-06-30 | $44.40M 10-K · filed 2024-03-28 |
| 2022-06-30 | $45.79M 10-K · filed 2023-03-16 |
| 2021-06-30 | $176.10M 10-K · filed 2022-03-31 |
| 2020-06-30 | $19.66M 10-K · filed 2021-03-23 |
| 2019-06-28 | $11.22M 10-K · filed 2020-03-13 |
| 2018-06-29 | $14.43M 10-K · filed 2019-03-22 |
| 2017-06-30 | $21.64M 10-K · filed 2018-04-13 |
| 2016-06-30 | $85.41M 10-K · filed 2017-03-15 |
| 2015-06-30 | $275.10M 10-K/A · filed 2016-04-15 |
| 2014-06-30 | $185.71M 10-K · filed 2015-03-05 |
| 2013-06-28 | $185.71M 10-K · filed 2014-03-17 |
| 2012-06-30 | $111.37M 10-K · filed 2013-03-12 |
| 2011-06-30 | $41.00M 10-K · filed 2012-03-28 |
| 2010-06-30 | $39.73M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |